Big Buttons

• PCAC to discuss 503A bulks list substances

  FDA’s Pharmacy Compounding Advisory Committee has announced that it will hold two meetings (!) between now and year-end to consider recommending several bulk drug substances to the 503A Bulks List.  read more →

• Next APC regional meeting: Seattle

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Seattle area October 3. read more →

• Don’t skip EduCon’s final (fantastic) session(s)

  The final session of this year’s EduCon is coming up in just a few weeks, and it’s a special double helping of legal goodness. read more →

• Welcome, new PFMs!

  We’ve added 31 Pharmacy-Facility Members since February! read more →

• Let’s talk about that Lilly announcement

  There’s been plenty of coverage of Eli Lilly’s announcement this week that it will sell vials of Zepbound directly to consumers at a discount. But the company seems to have left out a few important caveats. read more →

• Our response to the op-ed in The Hill

  The Hill published an editorial by Dr. Kenneth McCall titled “Fake, unsafe weight-loss drugs are a worsening public health dilemma” in which he makes unfounded claims about pharmacy compounding. Here’s the response from our CEO. read more →

• The shortage ends … then what? (Find out at CCH) 

  We’ve added a new session to the Compounders on Capitol Hill lineup. Don’t miss the discussion of what’s on many a compounder’s (and regulators’ … and reporters’...) mind. read more →

• A new bronze corporate patron

  A big welcome to Ro, APC’s newest tier-level corporate patron! read more →

More News

If you missed the first EduCon session last week, you’re not too late. You can still get four hours of live CE (and the two hours you missed can be claimed as home study credit).

The second session of EduCon, APC’s virtual ethical compounding learning series, is coming up soon — on August 19, in fact. This session is “Practice Pearls for Line Pharmacists and Technicians: USP 795, 797, and 800” featuring Michael Shafor, PharmD, of the LP3 Network. 

The third session, “Law: Helping Prescribers Navigate Compounding’s Regulatory Environment” and “Patient Safety: What 795 Doesn’t Talk About” is on September 23.

We know you’re busy, but it’s great practical training on the hottest topics in compounding right now. Register here (and bring your friends to get a discount).